Home List your patent My account Help Support us

Home DNA & RNA Patch for Instant Disease Screening Patent Pending

[Category : - HEALTH]
[Viewed 402 times]

This invention is a skin patch diagnostic platform that captures and analyzes DNA and RNA fragments circulating in sweat and interstitial fluid, enabling instant genetic and infectious disease screening at home.

The patch integrates:

Microneedle array (painless, penetrating only outer skin layers) to collect trace DNA/RNA.

On-patch CRISPR-based detection for rapid identification of genetic markers, viruses, and cancers.

AI-driven analysis that compares detected sequences to a cloud-based library of known pathogens and genetic risks.

Smartphone connectivity for secure reporting and integration into telehealth systems.

It solves the problem of slow, centralized, and expensive lab-based testing, which delays diagnosis and treatment.

Benefits over existing diagnostics:

Instant results at home ? No labs or long wait times.

Multi-condition detection ? Works for cancers, infections, genetic predispositions.

Non-invasive and painless ? Unlike blood draws or biopsies.

Scalable ? Patch costs low enough for routine, population-wide screening.

This invention turns the skin into a living diagnostic interface, democratizing precision medicine.

Financial information

The global genetic testing market is projected to exceed $40 billion by 2032, driven by consumer demand and falling costs of sequencing.

The infectious disease diagnostics market exceeds $100 billion, accelerated by COVID-19 and future pandemic preparedness.

Delayed diagnosis costs healthcare systems trillions annually in late-stage disease treatment.

Revenue pathways:

Direct-to-consumer sales for health-conscious users and families.

Partnerships with insurers to reduce costs by early detection.

Government contracts for population-level screening and pandemic monitoring.

Licensing to biotech & pharma for clinical trial monitoring and genetic risk research.

By merging wearables, genomics, and CRISPR diagnostics, this invention creates the world’s first consumer-grade, at-home DNA/RNA testing patch — unlocking mass adoption of precision diagnostics.

Patent publications:

No publication

Asking price:

100,000 USD

Rate this patent

Great invention
Viewed: 402 times

Seller:

chels99 (United Kingdom)

Ask a question
or start a negotiation

Contact the seller

Share on social media